Themis Bioscience GmbH

Erich Tauber is co-founder and has been CEO of Themis since its inception in 2009.
He has been working in the pharmaceutical and biotechnology industry since 2000 and has served in various roles with increasing responsibilities at AstraZeneca, Baxter, Intercell and Nycomed. In particular, he was responsible for the development and commercialization of Ixario, the first Japanese Encephalitis vaccine. He is a renowned expert in the field of vaccine and product development and a frequent author of scientific publications and speaker at corporate conventions.
He received his medical training at the University of Vienna and holds a medical Doctorate from the Medical University in Vienna. Before joining the industry, he was a pediatric research fellow at the Vienna University Children’s Hospital and the Southampton Children’s Hospital, UK.